Plasma serotonin levels are normal in pulmonary arterial hypertension
- PMID: 17374499
- PMCID: PMC2267916
- DOI: 10.1016/j.pupt.2007.01.003
Plasma serotonin levels are normal in pulmonary arterial hypertension
Abstract
Serotonin (5-HT) has been implicated in the pathogenesis of pulmonary arterial hypertension (PAH). We hypothesized that plasma 5-HT would be elevated in PAH related to associated conditions. We performed a prospective cohort study of 21 patients with PAH undergoing initial right heart catheterization and 6 healthy controls. Platelet-free plasma 5-HT levels were similar in patients with idiopathic PAH, PAH related to associated conditions, and healthy controls. Higher 5-HT levels correlated with increased six-minute walk distance (r=0.55, p=0.04). These data suggest that plasma 5-HT levels are normal in PAH. Plasma 5-HT may therefore not be a useful biomarker in this condition.
Figures
Similar articles
-
Venous plasma serotonin is not a proper biomarker for pulmonary arterial hypertension.Scand Cardiovasc J. 2014 Apr;48(2):106-10. doi: 10.3109/14017431.2014.886335. Epub 2014 Feb 24. Scand Cardiovasc J. 2014. PMID: 24446683
-
High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy.Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2233-9. doi: 10.1161/01.atv.20.10.2233. Arterioscler Thromb Vasc Biol. 2000. PMID: 11031209 Clinical Trial.
-
Aspirin attenuates pulmonary arterial hypertension in rats by reducing plasma 5-hydroxytryptamine levels.Cell Biochem Biophys. 2011 Sep;61(1):23-31. doi: 10.1007/s12013-011-9156-x. Cell Biochem Biophys. 2011. PMID: 21327581
-
Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension.PLoS One. 2018 May 29;13(5):e0197700. doi: 10.1371/journal.pone.0197700. eCollection 2018. PLoS One. 2018. PMID: 29813091 Free PMC article.
-
Serotonin transporter and serotonin receptors.Handb Exp Pharmacol. 2013;218:365-80. doi: 10.1007/978-3-642-38664-0_15. Handb Exp Pharmacol. 2013. PMID: 24092348 Review.
Cited by
-
Comparison of pre-analytical conditions for quantification of serotonin in platelet-poor plasma.Pract Lab Med. 2019 Sep 19;17:e00136. doi: 10.1016/j.plabm.2019.e00136. eCollection 2019 Nov. Pract Lab Med. 2019. PMID: 31649988 Free PMC article.
-
The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series).Pulm Circ. 2018 Apr-Jun;8(2):2045894018759125. doi: 10.1177/2045894018759125. Pulm Circ. 2018. PMID: 29468941 Free PMC article.
-
Metabolic Profiling of Right Ventricular-Pulmonary Vascular Function Reveals Circulating Biomarkers of Pulmonary Hypertension.J Am Coll Cardiol. 2016 Jan 19;67(2):174-189. doi: 10.1016/j.jacc.2015.10.072. J Am Coll Cardiol. 2016. PMID: 26791065 Free PMC article.
-
Platelets in pulmonary hypertension: a causative role or a simple association?Iran J Pediatr. 2012 Jun;22(2):145-57. Iran J Pediatr. 2012. PMID: 23056879 Free PMC article.
-
Low serum serotonin is associated with functional decline, mild behavioural impairment and brain atrophy in dementia-free subjects.Brain Commun. 2025 Jan 9;7(1):fcaf005. doi: 10.1093/braincomms/fcaf005. eCollection 2025. Brain Commun. 2025. PMID: 39816197 Free PMC article.
References
-
- Herve P, Launay JM, Scrobohaci ML, Brenot F, Simonneau G, Petitpretz P, Poubeau P, Cerrina J, Duroux P, Drouet L. Increased plasma serotonin in primary pulmonary hypertension. Am J Med. 1995;99:249–254. - PubMed
-
- Kereveur A, Callebert J, Humbert M, Herve P, Simonneau G, Launay JM, Drouet L. High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy. Arterioscler Thromb Vasc Biol. 2000;20:2233–2239. - PubMed
-
- Machado RD, Koehler R, Glissmeyer E, Veal C, Suntharalingam J, Kim M, Carlquist J, Town M, Elliott CG, Hoeper M, Fijalkowska A, Kurzyna M, Thomson JR, Gibbs SR, Wilkins MR, Seeger W, Morrell NW, Gruenig E, Trembath RC, Janssen B. Genetic association of the serotonin transporter in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2006;173:793–797. - PubMed
-
- Willers ED, Newman JH, Loyd JE, Robbins IM, Wheeler LA, Prince MA, Stanton KC, Cogan JA, Runo JR, Byrne D, Humbert M, Simonneau G, Sztrymf B, Morse JA, Knowles JA, Roberts KE, McElroy JJ, Barst RJ, Phillips JA., 3rd Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med. 2006;173:798–802. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases